Search Results
Dec 10, 2025, 12:24 ET Jiangyin concluye el mes de inversión de otoño dorado con 208 proyectos por un total de 68.000 millones de yuanes
instituciones académicas y de investigación nacionales para formar la Alianza Universitaria para la Transferencia y la Comercialización de Tecnología "Sci-tech Innovations in Jiangyin" (Innovaciones científicas y tecnológicas en Jiangyin). La alianza tiene como objetivo desarrollar nuevos modelos para transformar
More news about: Jiangyin Municipal Committee and Government
Dec 10, 2025, 04:35 ET IITM Pravartak in Partnership With Simplilearn, Launches 'The Smart Shield: AI-Powered Cybersecurity Mastery Program'
benefit from certifications such as Microsoft Certified: Azure AI Fundamentals (AI-900) and Microsoft Certified: Security, Compliance, and Identity (SCI) Fundamentals (SC-900) will deepen understanding of cognitive services and data protection within Microsoft ecosystems.Speaking about the program,
More news about: Simplilearn Solutions Private Limited
Dec 09, 2025, 22:43 ET Jiangyin conclut le mois de l'automne doré de l'investissement avec 208 projets totalisant 68 milliards de RMB
institutions universitaires et de recherche nationales pour former l'alliance universitaire pour le transfert et la commercialisation des technologies « Sci-tech Innovations in Jiangyin » . L'alliance vise à développer de nouveaux modèles pour traduire la recherche et les percées technologiques en applications
More news about: Jiangyin Municipal Committee and Government
Dec 09, 2025, 22:41 ET Jiangyin schließt Golden Autumn Investment Month mit 208 Projekten im Gesamtwert von 68 Mrd. RMB ab
inländischen Hochschul- und Forschungseinrichtungen zusammen und gründete die Universitätsallianz für Technologietransfer und Kommerzialisierung, die „Sci-tech Innovations in Jiangyin". Ziel der Allianz ist es, neue Modelle für die Umsetzung von Forschung und technologischen Durchbrüchen in kommerzielle Anwendungen
More news about: Jiangyin Municipal Committee and Government
Dec 09, 2025, 19:26 ET Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
Med. 2022;10(2):134-145[2]. Sci Rep. 2025;15(1):3310.[3]. Sun
More news about: Innovent Biologics
Dec 09, 2025, 09:00 ET AUTUMN BAILEY ENTERTAINMENT AND TY WALKER'S BRAVEHEART ENTERTAINMENT PARTNER WITH ASSEMBLY STUDIOS TO POWER A NEW ERA OF INDEPENDENT FILMMAKING IN ATLANTA
formats, Braveheart projects are defined by authenticity, innovation, and cross-cultural appeal. Walker's credits include executive producer on the sci-fi feature Xeno and producer on the action film Die Hart for Amazon.
More news about: Universal Studios, Inc.
Dec 09, 2025, 08:30 ET PTC Launches Arena AI Engine to Accelerate Intelligent Automation Across PLM and QMS Workflows
Arena Supply Chain Intelligence (SCI) features, including:Enhancements to the Arena AI Assistant to add support with more Help topics and full multilingual availability,
More news about: PTC Inc.
Dec 09, 2025, 04:37 ET Jiangyin Concludes Golden Autumn Investment Month with 208 Projects Totaling RMB68 Billion
Davide said. During the symposium, Jiangyin joined with Tsinghua University and other domestic academic and research institutions to form the "Sci-tech Innovations in Jiangyin" University Alliance for Technology Transfer and Commercialization. The alliance aims to develop new models for translating
More news about: Jiangyin Municipal Committee and Government
Dec 09, 2025, 04:21 ET Jiangyin Concludes Golden Autumn Investment Month with 208 Projects Totaling RMB68 Billion
Davide said. During the symposium, Jiangyin joined with Tsinghua University and other domestic academic and research institutions to form the "Sci-tech Innovations in Jiangyin" University Alliance for Technology Transfer and Commercialization. The alliance aims to develop new models for translating
More news about: Jiangyin Municipal Committee and Government
Dec 08, 2025, 14:00 ET Tiger BioSciences Highlights Study on Advanced Placental CAMP Technologies
Landa, O.; King, A.R.; Valdes Cavazos, D.; Marquez, J.; Hill, S. Native Wound-Repair Proteins Retained in Multilayer Placental CAMPs. Int. J. Mol. Sci. 2025, 26, 10121.
More news about: Tiger BioSciences
Dec 08, 2025, 12:00 ET Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
doi:10.4155/fmc.13.214Matkar S, Thiel A, Hua X. Menin: a scaffold protein that controls gene expression and cell signaling. Trends Biochem Sci. 2013;38(8):394-402. doi:10.1016/j.tibs.2013.05.005Kühn MW, Song E, Feng Z, et al. Targeting Chromatin Regulators Inhibits Leukemogenic Gene
More news about: Sumitomo Pharma America
Dec 08, 2025, 08:00 ET Adient Formed a Joint Venture with SCI to Drive Growth in China
Dec. 8, 2025 /PRNewswire/ -- Recently, Adient, a global leader in automotive seating, completed the acquisition of a 49% equity stake in SCI (Zhangjiakou) Co., Ltd., a local Chinese supplier under Zhejiang Yoening Technology Group, officially establishing a new strategic joint venture. This
More news about: Adient
Dec 08, 2025, 07:00 ET UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
Male. Children (Basel). 2022;9(12):1806.6 Jakimiec M, et al. CDKL5 Deficiency Disorder—A Complex Epileptic Encephalopathy. Brain Sci. 2020;10(2):107.7 Hong W, et al. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment. CNS Drugs.
More news about: UCB
Dec 08, 2025, 04:13 ET SJTU International Gen Z Students Explore Shanghai's Innovation Ecosystem
world-class innovation ecosystem (July 9-24). Their firsthand experiences form the foundation of the university's ongoing "Gen Z Perspectives on Shanghai's Sci-Tech Innovation" media initiative. The project documents in-depth stories of AI and smart manufacturing advancements through the students' lens, creating
More news about: Antai College of Economics and Management, Shanghai Jiao Tong University
Dec 08, 2025, 03:57 ET SJTU International Gen Z Students Explore Shanghai's Innovation Ecosystem
world-class innovation ecosystem (July 9-24). Their firsthand experiences form the foundation of the university's ongoing "Gen Z Perspectives on Shanghai's Sci-Tech Innovation" media initiative. The project documents in-depth stories of AI and smart manufacturing advancements through the students' lens, creating
More news about: Antai College of Economics and Management, Shanghai Jiao Tong University
Dec 08, 2025, 01:32 ET UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Male. Children (Basel). 2022;9(12):1806.[6] Jakimiec M, et al. CDKL5 Deficiency Disorder—A Complex Epileptic Encephalopathy. Brain Sci. 2020;10(2):107.[7] Hong W, et al. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment. CNS Drugs.
More news about: UCB
Dec 08, 2025, 01:28 ET UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Male. Children (Basel). 2022;9(12):1806.[6] Jakimiec M, et al. CDKL5 Deficiency Disorder—A Complex Epileptic Encephalopathy. Brain Sci. 2020;10(2):107.[7] Hong W, et al. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment. CNS Drugs.
More news about: UCB
Dec 05, 2025, 17:45 ET AL-S Pharma Reports Positive Results from Phase 2 Study of AP-101 for the Treatment of ALS, Supporting Plans for a Confirmatory Phase 3 Study
NCT05039099).1Maier M et al., Sci Transl Med. 2018;10(470).2Marlow TR et al., Neurobiol Dis. 2025;216:107124.About AP-101AP-101 is an investigational
More news about: AL-S Pharma AG
Dec 04, 2025, 11:00 ET Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
vCampbell WW, et al. J Gerontol A Biol Sci Med Sci. 2023;78(1):67–72.vi
More news about: Abbott
Dec 03, 2025, 18:10 ET Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025
doi:10.1038/s41467-021-23507-zOno K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.
More news about: Eisai Inc.
Dec 03, 2025, 12:30 ET THE HOLIDAYS ARE BRUTAL, PLUTO TV LETS YOU FIGHT BACK (FOR FREE)
Powers), this collection brings together 70+ of the biggest, boldest and most beloved action hits of all time.The brutality continues across sci-fi, horror, crime and historical epics, offering something for every kind of holiday-induced meltdown. Fans can escape into the worlds of The Terminator,
More news about: Pluto TV
Dec 02, 2025, 16:40 ET New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.Horie et al., CSF MTBR-tau243 is a specific biomarker of tau
More news about: Eisai Inc.
Dec 01, 2025, 09:00 ET Argent Trust Appoints Kade McDonald as Vice President, Business Development in Shreveport
and accounting from Louisiana State University. Active in his community, he serves as chairman of the board of directors for Red River STEM, LLC dba Sci-Port Discovery Center, and is a member of the North Louisiana Angel Fund Due Diligence Committee."Argent distinguishes itself through its unwavering
More news about: Argent Financial Group
Nov 29, 2025, 23:17 ET Чэнду становится глобальным инновационным центром в 14-й пятилетке
и офлайн-сервисов, предоставляемые «платформой Sci-Tech Express и островом Sci-Tech Island» оптимизировали процесс коммерциализации инноваций. На острове Sci-Tech Island работает 102 поставщика услуг, предлагающих 104 вида услуг, а онлайн-платформа Sci-Tech Express предоставила услуги научно-техническим
More news about: Chengdu Science and Technology Bureau
Nov 29, 2025, 23:13 ET Chengdu wird zum globalen Innovationszentrum während der Laufzeit des 14. Fünfjahresplans
Offline-Servicesysteme, die durch „Sci-Tech Express plus Sci-Tech Island" repräsentiert werden, haben die Kommerzialisierung von Innovationen vereinfacht. Die Offline-Plattform Sci-Tech Island hat 102 Dienstleister, die 104 verschiedene Services anbieten, während die Online-Plattform Sci-Tech Express schon über
More news about: Chengdu Science and Technology Bureau